Clinical trial
Circulating Tumor Cells and Tumor DNA in HCC and NET - Patient-specific Biomarkers for Clinical Decision Support and Tailored Relapse Diagnostics
NCT02973204 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating Tumor Cells and Tumor DNA in HCC and NET - Patient-specific Biomarkers for Clinical Decision Support and Tailored Relapse Diagnostics
- Lead sponsor
- University of Aarhus
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- January 8, 2020
- Enrollment
- 167 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.